Zusammenfassung
Während viele Maßnahmen in der Intensivmedizin supportiv sind, ermöglichen Antibiotika eine kausale Therapie. Die Auswahl erfolgt jedoch meist vor dem mikrobiologischen Nachweis, sodass sich die kalkulierte Therapie an den wahrscheinlichsten Erregern orientieren muss. Deutliche regionale Unterschiede bedingen, dass für viele Infektionen zwar ein typisches, aber nicht allgemein gültiges Erregerspektrum angegeben werden kann.
Literatur
Beaucaire C (2000) Does once-daily dosing prevent nephrotoxicity in all Aminoglykosides equally? Clin Microbiol Infect 6:357–362
Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient – concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014 Nov 20:77:3–11
Bodmann KF, Grabein B und die Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (2010) Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2010, ISBN 978-3-00-031623-4. www.p-e-g.org
Brunkhorst FM, Oppert M, Marx G et al (2012) Effect of empirical treatment with Moxifloxacin and Meropenem vs Meropenem on sepsis-related organ dysfunction in patientes with severe sepsis. JAMA 307:2390–2399
Bundesgesundheitsblatt Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen (2012) Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 55:1311–1354
Bundesgesundheitsblatt Prävention der nosokomialen Pneumonie (2013) Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 56:1578–1590
CDC (2004) CDC-Guidelines Morbid Mortal Weekly Report 53: RR 3
CDC (2011) Guidelines for the prevention of intravascular catheter-related infections, HICPAC guidelines, CDC. www.cdc.gov
Chastre J et al (2003) The PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. A randomized trial. JAMA 290:2588–2598
Chien JW, Johnson JL (2000) Viral pneumonias. Infection in the immunocompromised host. Postgrad Med 107:67–80
Climo MW, Yokoe DS, Warren DK et al (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542
Cunha BA (1999) Fever in the intensive care unit. Intensive Care Med 25:648–651
Dahlhoff K, Abele-Horn M, Andreas S et al (2012) Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. Pneumologie 66:707–765
de Gans J, von de Beek D (2001) The European dexamethasone in adulthood bacterial meningitis study investigators. N Engl J Med 347:1549–5649
Dettenkofer M, Wilson C, Gratwohl A et al (2009) Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial. J Compil Europ Soc Clin Microbio Infect Disea 50:691–703
Fabregas N, Ewig S, Torres A et al (1999) Clinical diagnosis of ventilator-associated pneumonia revised: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873
Gastmeier P, Sohr D, Geffers C et al (2005) Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German nosocomial infection surveillance system (KISS). Infection 33:50–55
Geiss HK (1999) Nosocomial sinusitis (editorial). Intensive Care Med 25:1037–1039
Höffken G, Lorenz J, Kern W et al (2009) Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009. S3-Leitlinie der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, der Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ. Pneumologie 63:e1–e68
Holzapfel L, Chastang C, Demingeon G et al (1999) A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia. Am J Respir Crit Care Med 159:695–701
Huang SS, Septimus E, Kleinman K et al (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265
Johanson WG, Pierce AK, Sanford JP, Thomas GD (1972) Nosocomial respiratory infections with Gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 77:701–706
Kollef MH, Hamilton CW, Montgomery AB (2013) Aerosolized antibiotics: do they add to the treatment of pneumonia? Curr Opin Infect Dis 26:538–544
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections. Chest 115:462–474
Krueger WA, Bulitta J, Kinzig-Schippers M et al (2005) Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers. Antimicrob Agents Chemother 49:1881–1889
Krueger WA, Lenhart F-P, Neeser G et al (2002–2003) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients. A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166:1029–1037
Krueger WA, Ruckdeschel G, Unertl K (1997) Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate. Antimicrob Agents Chemother 41:1725–1730
Krueger WA, Ruckdeschel G, Unertl K (1999) Elimination of fecal Enterobacteriaceae by intravenous ciprofloxacin is not inhibited by concomitant sucralfate – a microbiological and pharmacokinetic study in patients. Infection 27:335–340
Krueger WA, Unertl KE (2000) Die geschichtliche Entwicklung der Intensivmedizin in Deutschland. Zeitgenössische Betrachtungen Anästhesist 49:743–751
Krueger WA, Unertl KE (2002) Selective decontamination of the digestive tract: current status. Curr Opin Crit Care 8:139–144
Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
Lee CS, Doi Y (2014) Therapy of infections due to carbapenem-resistant gram-negative pathogens. Infect Chemother 46:149–164
Lemmen SW, Engels I, Daschner FD (1997) Serum bactericidal activity of ceftazidime administered as continuous infusion of 3 g over 24 h vs. intermittent bolus infusion of 2 g against Pseudomonas aeruginosa in healthy volunteers. J Antimicrob Chemother 39:841–842
Le Moal G, Lemerre D, Grollier G et al (1999) Nosocomial sinusitis with isolation of anaerobic bacteria in ICU patients. Intensive Care Med 25:1066–1071
Lindsay E, Bradley NS, Colgan R et al (2005) Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:643–654. www.journals.uchicago.edu/CID/journal/issues/v40n5/35309/35309.text.html
Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the infectious diseases society of America for the treatment of methicilin-resistant Staphylococcus aureus infection in adults and children. Clin Infect Dis 52:1–38
Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 196:1305–1309
Marik PE (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344:665–671
Marra AR, Edmond MB, Forbes BA et al (2006) Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol 44:1342–1346
Marschall J, Mermel LA, Fakih M et al (2014) Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35:753–771
Meduri GU, Mauldin GL, Wunderink RG et al (1994) Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 106:221–235
Mermel LA, Farr BM, Sherertz RJ et al (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249–1272
Mutters NT, Mersch-Sundermann V, Mutters R et al (2013) Kontrolle von Vancomycin-resistenten Enterokokken im Krankenhaus. Dtsch Ärztebl 110:725–731
Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177:498–505
Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668
Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National nosocomial infections surveillance system. Crit Care Med 27:887–892
Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498–509
Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30:11–18
Scheithauer S, Lewalter L, Schröder J et al (2014) Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection 42:155–159
Scheithauer S, Manemann AK, Krüger S et al (2010) Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection 38:401–405
Schwaber MJ, Nacon-Venezia S, Kaye KS et al (2006) Clinical and economie impact of bacteremia with extended spectrum beta lactamase producin Enterobacteriaceae. Antimicrob Agents Chemother 50:1257–1262
Stevens DL, Bisno AL, Chambers HF et al (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41:1373–1406
Talmor M, Li P, Barie PS (1997) Acute paranasal sinusitis in critically ill patients: guidelines for prevention, diagnosis, and treatment. Clin Infect Dis 25:1441–1446
The Canadian Critical care Trials Group (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355:2619–2630
Timsit JF, Mimoz O, Mourvillier B et al (2012) Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 186:1272–1278
Tumbarello M, Pascale GD, Trecarichi EM et al (2013) Effect of aerosolized colistin as adjunctive treatment on the outcomes of micobiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. Chest 144:1768–1775
Tunkel AR, Hartman BJ, Kaplan SL et al (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–1284
Weinstein RA (1986) Endemic emergence of resistance of cephalosporin-resistant enterobacter: relation to prior therapy. Infect Control 7:120–123
Wunderink RG, Niedermann MS, Kollef MH et al (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54:621–629
Wunderink RG, Woldenberg LS, Zeiss J et al (1992) The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 101:458–463
Dulhunty JM, Roberts JA, Joshua SD et al. (2015) A multicenter randomized trial of continuous versus intermittend β-lactam infusion in severe sepsis. Am J Respir Crit Care Med 192:1298–1305
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2015 © Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Lemmen, S., Lewalter, K., Krüger, W. (2015). Intensivmedizinische Aspekte der Antibiotikatherapie. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45539-5_139-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-45539-5_139-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45539-5
Online ISBN: 978-3-662-45539-5
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Intensivmedizinische Aspekte der Antibiotikatherapie- Published:
- 15 March 2018
DOI: https://doi.org/10.1007/978-3-662-45539-5_139-2
-
Original
Intensivmedizinische Aspekte der Antibiotikatherapie- Published:
- 20 April 2017
DOI: https://doi.org/10.1007/978-3-662-45539-5_139-1